Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Bilenker Joshua H. Create: Alert

All | News | Filings
Date FiledTypeDescription
06/09/2023 4 Bilenker Joshua H. (Director) has filed a Form 4 on Sana Biotechnology, Inc.
Txns: Granted 65,000 options to buy @ $6.7, valued at $435.5k
07/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2021 4 Bilenker Joshua H. (Director) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Granted 23,500 options to buy @ $8.97, valued at $210.8k
02/18/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
02/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/18/2020 4 Bilenker Joshua H. (Director) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Granted 23,500 options to buy @ $12.1, valued at $284.4k
06/11/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/07/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
01/17/2019 4/A Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Exercised 7,500 shares @ $1.184, valued at $8.9k
01/02/2019 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Granted 128,000 options to buy @ $139.77, valued at $17.9M
12/12/2018 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 969 shares @ $130.58, valued at $126.5k
Sold 2,001 shares @ $132.09, valued at $264.3k
Sold 2,104 shares @ $133, valued at $279.8k
Sold 2,049 shares @ $134.31, valued at $275.2k
Sold 2,377 shares @ $135.04, valued at $321k
Sold 400 shares @ $136.48, valued at $54.6k
Sold 100 shares @ $137.39, valued at $13.7k
Sold 647 shares @ $134.63, valued at $87.1k
Sold 1,153 shares @ $135.76, valued at $156.5k
Sold 3,393 shares @ $136.79, valued at $464.1k
Sold 2,407 shares @ $137.63, valued at $331.3k
11/28/2018 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 2,638 shares @ $138.94, valued at $366.5k
Sold 700 shares @ $140.14, valued at $98.1k
Sold 690 shares @ $141.48, valued at $97.6k
Sold 634 shares @ $142.45, valued at $90.3k
Sold 859 shares @ $143.35, valued at $123.1k
Sold 700 shares @ $144.61, valued at $101.2k
Sold 600 shares @ $147.09, valued at $88.3k
Sold 250 shares @ $148.06, valued at $37k
Sold 400 shares @ $149.25, valued at $59.7k
Sold 200 shares @ $151.56, valued at $30.3k
Exercised 29,000 options to buy @ $1.184, valued at $34.3k
10/05/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/14/2018 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 700 shares @ $164.1594, valued at $114.9k
Sold 3,700 shares @ $165.1821, valued at $611.2k
Sold 2,400 shares @ $166.4875, valued at $399.6k
Sold 1,800 shares @ $167.3814, valued at $301.3k
Sold 800 shares @ $168.5125, valued at $134.8k
Sold 200 shares @ $169.8872, valued at $34k
Sold 400 shares @ $171.075, valued at $68.4k
Sold 5,636 shares @ $165.425, valued at $932.3k
Sold 3,402 shares @ $166.523, valued at $566.5k
Sold 962 shares @ $167.3169, valued at $161k
Exercised 10,000 options to buy @ $1.184, valued at $11.8k
08/15/2018 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 1,600 shares @ $157.6677, valued at $252.3k
Sold 4,233 shares @ $158.5098, valued at $671k
Sold 3,367 shares @ $159.6267, valued at $537.5k
Sold 800 shares @ $160.4862, valued at $128.4k
Sold 1,600 shares @ $159.1263, valued at $254.6k
Sold 7,100 shares @ $159.9311, valued at $1.1M
Sold 1,300 shares @ $160.7508, valued at $209k
Exercised 10,000 options to buy @ $1.184, valued at $11.8k
Exercised 10,000 options to buy @ $1.184, valued at $11.8k
07/11/2018 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 900 shares @ $184.8698, valued at $166.4k
Sold 1,500 shares @ $186.3849, valued at $279.6k
Sold 3,698 shares @ $187.3871, valued at $693k
Sold 802 shares @ $188.2849, valued at $151k
Sold 300 shares @ $189.43, valued at $56.8k
Sold 300 shares @ $191.6333, valued at $57.5k
Sold 2,200 shares @ $178.1923, valued at $392k
Sold 2,200 shares @ $179.0809, valued at $394k
Sold 1,000 shares @ $180.081, valued at $180.1k
Sold 1,300 shares @ $181.2077, valued at $235.6k
Sold 800 shares @ $182.8388, valued at $146.3k
06/21/2018 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Gifted 5,000 shares @ $0
Sold 2,336 shares @ $176.2016, valued at $411.6k
Sold 3,427 shares @ $177.0556, valued at $606.8k
Sold 1,737 shares @ $178.1172, valued at $309.4k
Sold 8,232 shares @ $177.4359, valued at $1.5M
Sold 8,763 shares @ $178.297, valued at $1.6M
Sold 3,902 shares @ $179.8333, valued at $701.7k
Sold 103 shares @ $180.3368, valued at $18.6k
Sold 2,700 shares @ $178.8052, valued at $482.8k
Sold 4,370 shares @ $179.3697, valued at $783.8k
Sold 430 shares @ $180.8965, valued at $77.8k
05/16/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/26/2018 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 1,717 shares @ $129.3516, valued at $222.1k
Sold 1,283 shares @ $130.6232, valued at $167.6k
Sold 1,500 shares @ $131.7567, valued at $197.6k
Sold 2,490 shares @ $132.5426, valued at $330k
Sold 510 shares @ $133.4851, valued at $68.1k
Sold 800 shares @ $128.3045, valued at $102.6k
Sold 800 shares @ $129.4438, valued at $103.6k
Sold 2,400 shares @ $130.7121, valued at $313.7k
Sold 3,400 shares @ $131.8418, valued at $448.3k
Sold 100 shares @ $132.53, valued at $13.3k
Exercised 7,500 options to buy @ $1.184, valued at $8.9k
03/15/2018 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 300 shares @ $128.5733, valued at $38.6k
Sold 1,100 shares @ $129.9665, valued at $143k
Sold 1,800 shares @ $130.6906, valued at $235.2k
Sold 1,715 shares @ $131.7597, valued at $226k
Sold 1,094 shares @ $132.5781, valued at $145k
Sold 1,491 shares @ $133.5044, valued at $199.1k
Sold 1,800 shares @ $130.6584, valued at $235.2k
Sold 4,300 shares @ $131.5983, valued at $565.9k
Sold 1,400 shares @ $132.255, valued at $185.2k
Exercised 7,500 options to buy @ $1.184, valued at $8.9k
Exercised 7,500 options to buy @ $1.184, valued at $8.9k
02/14/2018 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 1,250 shares @ $91.7623, valued at $114.7k
Sold 1,207 shares @ $92.6139, valued at $111.8k
Sold 3,942 shares @ $93.7701, valued at $369.6k
Sold 1,101 shares @ $94.6842, valued at $104.2k
Sold 1,100 shares @ $94.4445, valued at $103.9k
Sold 413 shares @ $96.4718, valued at $39.8k
Sold 100 shares @ $97.14, valued at $9.7k
Sold 400 shares @ $98.6225, valued at $39.4k
Sold 791 shares @ $100.3344, valued at $79.4k
Sold 3,996 shares @ $101.1888, valued at $404.4k
Sold 700 shares @ $102.2029, valued at $71.5k
01/18/2018 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 2,919 shares @ $86.4236, valued at $252.3k
Sold 1,604 shares @ $87.1245, valued at $139.7k
Sold 600 shares @ $88.7767, valued at $53.3k
Sold 1,577 shares @ $89.9387, valued at $141.8k
Sold 800 shares @ $90.4964, valued at $72.4k
Sold 1,104 shares @ $86.1929, valued at $95.2k
Sold 1,042 shares @ $87.1416, valued at $90.8k
Sold 2,672 shares @ $88.8921, valued at $237.5k
Sold 2,682 shares @ $89.5249, valued at $240.1k
Exercised 7,500 options to buy @ $1.184, valued at $8.9k
Exercised 7,500 options to buy @ $1.184, valued at $8.9k
01/05/2018 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Granted 300,000 options to buy @ $84.88, valued at $25.5M
12/18/2017 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 2,600 shares @ $82.5465, valued at $214.6k
Sold 2,900 shares @ $83.4179, valued at $241.9k
Sold 2,000 shares @ $84.2935, valued at $168.6k
Sold 700 shares @ $76.9271, valued at $53.8k
Sold 2,268 shares @ $78.0645, valued at $177.1k
Sold 3,023 shares @ $78.9932, valued at $238.8k
Sold 609 shares @ $80.0822, valued at $48.8k
Sold 600 shares @ $80.8817, valued at $48.5k
Sold 100 shares @ $81.72, valued at $8.2k
Sold 200 shares @ $82.86, valued at $16.6k
Exercised 7,500 options to buy @ $1.184, valued at $8.9k
11/29/2017 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Gifted 6,000 shares @ $0
Sold 4,693 shares @ $74.1302, valued at $347.9k
Sold 1,601 shares @ $74.9838, valued at $120k
Sold 906 shares @ $76.1989, valued at $69k
Sold 300 shares @ $77.0733, valued at $23.1k
Sold 2,400 shares @ $73.1513, valued at $175.6k
Sold 2,460 shares @ $73.9936, valued at $182k
Sold 1,850 shares @ $75.2095, valued at $139.1k
Sold 790 shares @ $75.8524, valued at $59.9k
Exercised 7,500 options to buy @ $1.184, valued at $8.9k
Exercised 7,500 options to buy @ $1.184, valued at $8.9k
11/01/2017 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 5,690 shares @ $86.8752, valued at $494.3k
Sold 998 shares @ $87.7386, valued at $87.6k
Sold 812 shares @ $88.7737, valued at $72.1k
Sold 2,961 shares @ $86.1788, valued at $255.2k
Sold 4,339 shares @ $86.6545, valued at $376k
Sold 200 shares @ $87.665, valued at $17.5k
Exercised 7,500 options to buy @ $1.184, valued at $8.9k
Exercised 7,500 options to buy @ $1.184, valued at $8.9k
09/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/16/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/17/2017 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Granted 100,000 options to buy @ $43.56, valued at $4.4M
12/08/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
09/15/2016 4 Bilenker Joshua H. (10% Owner) has filed a Form 4 on ViewRay, Inc.
Txns: Granted 18,964 shares @ $0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy